PL2900270T3 - Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym - Google Patents
Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowymInfo
- Publication number
- PL2900270T3 PL2900270T3 PL13771104T PL13771104T PL2900270T3 PL 2900270 T3 PL2900270 T3 PL 2900270T3 PL 13771104 T PL13771104 T PL 13771104T PL 13771104 T PL13771104 T PL 13771104T PL 2900270 T3 PL2900270 T3 PL 2900270T3
- Authority
- PL
- Poland
- Prior art keywords
- oxazolepiperidines
- benzo
- iso
- combination
- linoleic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261705790P | 2012-09-26 | 2012-09-26 | |
| US201361871662P | 2013-08-29 | 2013-08-29 | |
| PCT/EP2013/070106 WO2014049071A1 (en) | 2012-09-26 | 2013-09-26 | Modulators of androgen synthesis |
| EP13771104.0A EP2900270B1 (en) | 2012-09-26 | 2013-09-26 | Combination of benzo(iso)oxazolepiperidines with conjugated linoleic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2900270T3 true PL2900270T3 (pl) | 2019-09-30 |
Family
ID=49293617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13771104T PL2900270T3 (pl) | 2012-09-26 | 2013-09-26 | Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US9072743B2 (pl) |
| EP (1) | EP2900270B1 (pl) |
| JP (2) | JP6434410B2 (pl) |
| CN (1) | CN104797271B (pl) |
| AU (2) | AU2013322612B2 (pl) |
| BR (1) | BR112015006727B1 (pl) |
| CA (1) | CA2886132C (pl) |
| ES (1) | ES2734554T3 (pl) |
| HK (1) | HK1211868A1 (pl) |
| IL (2) | IL237892B (pl) |
| MX (1) | MX367782B (pl) |
| NZ (1) | NZ706067A (pl) |
| PL (1) | PL2900270T3 (pl) |
| WO (1) | WO2014049071A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ706067A (en) | 2012-09-26 | 2016-07-29 | Tangent Reprofiling Ltd | Modulators of androgen synthesis |
| US9375433B2 (en) * | 2012-09-26 | 2016-06-28 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
| WO2015169971A1 (en) * | 2014-05-09 | 2015-11-12 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
| CN110199032A (zh) | 2017-01-23 | 2019-09-03 | 雷杰纳荣制药公司 | 羟基类固醇17-β脱氢酶13(HSD17B13)变体及其用途 |
| JP2020516283A (ja) | 2017-04-11 | 2020-06-11 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヒドロキシステロイド（１７−ベータ）デヒドロゲナーゼ（ｈｓｄ１７ｂ）ファミリーのメンバーのモジュレーターの活性をスクリーニングするためのアッセイ |
| KR20240125690A (ko) | 2017-10-11 | 2024-08-19 | 리제너론 파마슈티칼스 인코포레이티드 | Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4756911A (en) | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| ATE135216T1 (de) * | 1989-08-21 | 1996-03-15 | Beth Israel Hospital | Verwendung von spiperone-derivate zur immunosuppression |
| US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| TW376319B (en) * | 1993-04-28 | 1999-12-11 | Janssen Pharmaceutica Nv | Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine |
| US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| US6319950B1 (en) | 1997-02-18 | 2001-11-20 | Michael C. Seidel | Suppression of carcinoma using high purity conjugated linoleic acid (CLA) |
| JPH1192343A (ja) * | 1997-09-22 | 1999-04-06 | Shiseido Co Ltd | 毛髪成長期延長剤 |
| JPH11209279A (ja) * | 1998-01-05 | 1999-08-03 | Natural Ltd As | 体重減少および肥満処置の方法 |
| IL139975A0 (en) | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
| US6977271B1 (en) * | 2001-08-30 | 2005-12-20 | Health Research, Inc. | Method for inhibition of angiogenesis and vasculogenesis |
| ES2186576B1 (es) * | 2001-10-11 | 2004-09-16 | Universitat De Les Illes Balears | Acido 2-hidroxioleico para utilizar como medicamento. |
| EP1480629A1 (en) * | 2002-02-08 | 2004-12-01 | Abbott Laboratories | Combination therapy for treatment of schizophrenia |
| EP1626703A2 (en) * | 2003-05-22 | 2006-02-22 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
| WO2005066196A1 (en) * | 2003-12-30 | 2005-07-21 | Ranbaxy Laboratories Limited | Amorphous form of finasteride and processes for its preparation |
| JP2007518804A (ja) | 2004-01-20 | 2007-07-12 | アラーガン、インコーポレイテッド | トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物 |
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| RU2007142346A (ru) * | 2005-05-31 | 2009-07-20 | Ориксиджен Серапьютикс, Инкорпорэйтд (Сша/Сша) (Us) | Способы и составы для контроля психотических нарушений |
| WO2008034129A2 (en) * | 2006-09-15 | 2008-03-20 | Cornell Research Foundation Inc. | Treatment of cancer or obesity with conjugated linoleic acids |
| US8420624B2 (en) | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
| AR070313A1 (es) * | 2008-01-03 | 2010-03-31 | Gador Sa | Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma |
| US20090326070A1 (en) * | 2008-05-01 | 2009-12-31 | Complexa Inc. | Vinyl substituted fatty acids |
| CN101366705B (zh) * | 2008-09-28 | 2010-09-08 | 浙江大学 | 利培酮透皮吸收贴片 |
| US20110008406A1 (en) | 2009-04-20 | 2011-01-13 | Altman Gregory H | Silk Fibroin Hydrogels and Uses Thereof |
| WO2012026663A1 (ko) * | 2010-08-25 | 2012-03-01 | 이화여자대학교 산학협력단 | 운데실렌산, 공액리놀레산 및/또는 공액리놀레산 이성질체를 포함하는 항암보조제 |
| ES2634669T3 (es) * | 2011-02-08 | 2017-09-28 | Halozyme, Inc. | Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata |
| WO2014027973A1 (en) * | 2012-08-14 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Paliperidone oral solution |
| NZ706067A (en) | 2012-09-26 | 2016-07-29 | Tangent Reprofiling Ltd | Modulators of androgen synthesis |
| US9375433B2 (en) | 2012-09-26 | 2016-06-28 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
| WO2015169971A1 (en) | 2014-05-09 | 2015-11-12 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
-
2013
- 2013-09-26 NZ NZ706067A patent/NZ706067A/en unknown
- 2013-09-26 BR BR112015006727-1A patent/BR112015006727B1/pt active IP Right Grant
- 2013-09-26 ES ES13771104T patent/ES2734554T3/es active Active
- 2013-09-26 WO PCT/EP2013/070106 patent/WO2014049071A1/en active Application Filing
- 2013-09-26 PL PL13771104T patent/PL2900270T3/pl unknown
- 2013-09-26 JP JP2015532473A patent/JP6434410B2/ja active Active
- 2013-09-26 US US14/037,481 patent/US9072743B2/en active Active
- 2013-09-26 EP EP13771104.0A patent/EP2900270B1/en active Active
- 2013-09-26 CA CA2886132A patent/CA2886132C/en active Active
- 2013-09-26 AU AU2013322612A patent/AU2013322612B2/en active Active
- 2013-09-26 CN CN201380054623.0A patent/CN104797271B/zh active Active
- 2013-09-26 MX MX2015003899A patent/MX367782B/es active IP Right Grant
-
2015
- 2015-03-22 IL IL237892A patent/IL237892B/en active IP Right Grant
- 2015-05-27 US US14/723,225 patent/US9585887B2/en active Active
-
2016
- 2016-01-04 HK HK16100002.8A patent/HK1211868A1/xx unknown
-
2017
- 2017-02-27 US US15/444,066 patent/US9808462B2/en active Active
- 2017-08-31 AU AU2017221819A patent/AU2017221819B2/en active Active
- 2017-11-02 US US15/802,005 patent/US20180064713A1/en not_active Abandoned
-
2018
- 2018-11-08 JP JP2018210459A patent/JP6734346B2/ja active Active
-
2019
- 2019-05-05 IL IL266446A patent/IL266446A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1214259A1 (zh) | 衍生物 | |
| HK1206723A1 (en) | Thienopyrimidines | |
| EP2838564A4 (en) | ALPHA-D-GLUCANES HIGHLY RAMIFIED | |
| HK1211933A1 (en) | Haptens of olanzipine | |
| EP2812777A4 (en) | STRING COMPLETION | |
| EP2921192A4 (en) | CATHETER | |
| GB201221260D0 (en) | Turbine | |
| EP2823767A4 (en) | CATHETER | |
| EP2926857A4 (en) | CATHETER | |
| HK1208067A1 (zh) | 小容器 | |
| PL2807317T3 (pl) | Wieża hybrydowa | |
| PL2900270T3 (pl) | Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym | |
| GB201210980D0 (en) | Polyphosphazenes | |
| RS64838B1 (sr) | Turbine | |
| EP2810680A4 (en) | CATHETER | |
| GB2508089B (en) | Underpants | |
| SG11201505131UA (en) | Sphingomyelin-containing supplement | |
| SG11201406097SA (en) | Capsule formulation | |
| EP2910560A4 (en) | CARBOXYLIC ACID DERIVATIVE CONTAINING SILICON | |
| GB201201450D0 (en) | Watering lances | |
| GB201204760D0 (en) | Easy tees | |
| EP2900310A4 (en) | MULTI-WINDING CATHETER | |
| GB201316110D0 (en) | Phenylboronic Acid | |
| GB201204338D0 (en) | Dissolution of biomass | |
| GB201210923D0 (en) | Turbines |